M
Marksans Pharma
MARKSANS Share Price
Healthcare167.01
as on 13 Mar 2026 at 15:46
Market Cap
₹7,570 Cr
PE Ratio
21.70
ROCE
18.67%
MARKSANS Fundamentals
Company Valuation
Market Cap (₹ Cr.)
7,570
PE Ratio
21.70
PB Ratio
2.92
Dividend Yield
0.46%
ROE
15.37%
ROCE
18.67%
Book Value (₹)
59.32
Face Value (₹)
1.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% |
| Domestic Institutional Investors (DII) | 4.30% | 4.56% | 5.50% | 5.28% | 5.91% |
| Foreign Institutional Investors (FII) | 21.96% | 22.20% | 19.88% | 16.92% | 8.12% |
| Public Investors | 26.24% | 25.77% | 26.75% | 29.53% | 28.98% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
MARKSANS Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
524404
NSE Scrip Name
MARKSANS
ISIN
INE750C01026



